Abstract
► Barbeya oleoides is used as a remedy in the treatment of certain inflammatory diseases. ► Three new flavonol glycosides were isolated. ► Twelve known compounds were isolated, not previously reported in the family barbeyaceae. ► Extracts and compounds were tested for antimicrobial and spasmolytic activity.
Three new flavonol glycosides, 3′,5′ dimethoxymyricetin-4″-O-α-l-rhamnopyranosyl (1–4) β-d-glucopyranoside (1), 3′-methoxyquercetin-4″-O-α-l-rhamnopyranosyl (1–4) β-d-glucopyranoside (2) and 3′-methoxyqurecetin-6″-O-α-l-rhamnopyranosyl (1–6) β-d-glucopyranoside (3), have been isolated from the aerial part of Barbeya oleoides Schweinf., along with twelve known compounds, uvaol (4), ursolic acid (5), corosolic acid (6), arjunolic acid (7), β-sitosterol-3-O-β-d-glucoside (8), (+)–catechin (9), (-)-epicatechin (10), isorhamnetin-4′-O-glucoside (11), arjunglucoside I (12), d-(-)-bornesitol (13), gallocatechin (14) and epigallocatechin (15). Compounds 4–15 were isolated for the first time from Barbeyaceae. Structure elucidation of compounds 1–3 was based on MS and NMR data. The ethyl acetate extract of the stems as well as compounds 5, 6, 14 and 15 showed significant antimicrobial activity, while the ethanol extracts of leaves, stems and compounds 4, 7, 8, 13–15 have dose-dependent spasmolytic action.